Intuitive Surgical Stock Forecast, Price & News

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There are currently 5 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Intuitive Surgical stock.
View analyst ratings for Intuitive Surgical or view top-rated stocks.

18 Wall Street research analysts have issued 12 month price objectives for Intuitive Surgical's stock. Their ISRG stock forecasts range from $225.00 to $363.33. On average, they predict Intuitive Surgical's share price to reach $323.24 in the next year. This suggests a possible upside of 55.8% from the stock's current price.
View analysts' price targets for Intuitive Surgical or view top-rated stocks among Wall Street analysts.

Intuitive Surgical's stock was trading at $359.30 at the start of the year. Since then, ISRG stock has decreased by 42.2% and is now trading at $207.52.
View the best growth stocks for 2022 here.

Intuitive Surgical is scheduled to release its next quarterly earnings announcement on Thursday, July 21st 2022.
View our earnings forecast for Intuitive Surgical.

Intuitive Surgical will be holding an earnings conference call on Thursday, July 21st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Intuitive Surgical, Inc. (NASDAQ:ISRG) released its earnings results on Thursday, April, 21st. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.07. The medical equipment provider earned $1.49 billion during the quarter, compared to analysts' expectations of $1.43 billion. Intuitive Surgical had a trailing twelve-month return on equity of 14.16% and a net margin of 27.84%. The company's quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.17 EPS.
View Intuitive Surgical's earnings history.

Intuitive Surgical's stock split before market open on Tuesday, October 5th 2021. The 3-1 split was announced on Thursday, August 5th 2021. The newly issued shares were distributed to shareholders after the closing bell on Monday, October 4th 2021. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.

431 employees have rated Intuitive Surgical CEO Gary S. Guthart on Glassdoor.com. Gary S. Guthart has an approval rating of 99% among Intuitive Surgical's employees. This puts Gary S. Guthart in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Intuitive Surgical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX) and Abiomed (ABMD).
View all of ISRG's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Intuitive Surgical investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Salesforce (CRM), PayPal (PYPL), Walt Disney (DIS), Boeing (BA), Mastercard (MA) and Adobe (ADBE).

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

Intuitive Surgical's stock is owned by a number of institutional and retail investors. Top institutional investors include Park National Corp OH (0.00%) and GoalVest Advisory LLC (0.00%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Amy L Ladd, Craig H Barratt, Curet Myriam, David J Rosa, David J Rosa, Gary S Guthart, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Rubash, Mark J Rubash, Marshall Mohr, Myriam Curet, Neeraj Gupta, Reiter Kara Andersen, Robert Desantis and Salvatore Brogna.
View institutional ownership trends for Intuitive Surgical.

ISRG stock was sold by a variety of institutional investors in the last quarter, including GoalVest Advisory LLC. Company insiders that have sold Intuitive Surgical company stock in the last two years include Alan J Levy, Amal M Johnson, Amy L Ladd, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Mark J Rubash, Marshall Mohr, Myriam Curet, Reiter Kara Andersen, and Robert Desantis.
View insider buying and selling activity for Intuitive Surgical or view top insider-selling stocks.

ISRG stock was acquired by a variety of institutional investors in the last quarter, including Park National Corp OH.
View insider buying and selling activity for Intuitive Surgical or or view top insider-buying stocks.

Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ISRG stock can currently be purchased for approximately $207.52.

Intuitive Surgical (NASDAQ:ISRG) has a market capitalization of $74.49 billion and generates $5.71 billion in revenue each year. The medical equipment provider earns $1.70 billion in net income (profit) each year or $4.4967 on an earnings per share basis.

Intuitive Surgical employs 9,793 workers across the globe.

Intuitive Surgical was founded in 1995.

Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The official website for Intuitive Surgical is www.intuitive.com. The medical equipment provider can be reached via phone at (408) 523-2100, via email at investor.relations@intusurg.com, or via fax at 408-523-1390.